As of the latest SEC filings, Apimeds Pharmaceuticals US, Inc. (APUS) is held by 4 institutional funds. The largest fund shareholder is VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND (VITNX), holding an estimated $109,110.45 in market value, representing a significant portion of its portfolio.
Funds holding Apimeds Pharmaceuticals US, Inc. (APUS)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- APUS
- CIK:
- 0001894525
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VITNX
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND
|
MF | Vanguard | 0.00% | $109,110.45 | 60,976 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $62,544.90 | 34,953 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $32,300.00 | 23,750 | Feb 28, 2026 | Apr 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $13,231.44 | 9,729 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)